Showing results (521-530 of 694) with videos related to

Sort By:
Pageof 70
Parkinsonism & Related Disorders|April 13, 2012
Cortical myoclonus in childhood and juvenile onset Huntington's diseaseDavide Rossi Sebastiano, Paola Soliveri, Ferruccio Panzica, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|October 28, 2025
Kinematic alignment, but not mechanical alignment, preserves the knee-ankle relationship after total knee arthroplasty: A retrospective radiographic analysis from the FP-UCBM Knee Study GroupEdoardo Franceschetti, Giancarlo Giurazza, Marco Donantoni, et al.
The New Microbiologica|July 7, 2015
Neutrophil CD64 expression: a reliable diagnostic marker of infection in advanced cancer patients?Giuditta Comolli, Martina Torchio, Elisa Lenta, et al.
The American Journal of Pathology|March 30, 2010
Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murineHaitao Li, Xi Jiang, John Delaney, et al.
Computational Intelligence and Neuroscience|January 30, 2010
Simultaneous EEG-fMRI in patients with Unverricht-Lundborg disease: event-related desynchronization/synchronization and hemodynamic response analysisElisa Visani, Ludovico Minati, Laura Canafoglia, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 2, 2011
Recessive loss-of-function mutation in the pacemaker HCN2 channel causing increased neuronal excitability in a patient with idiopathic generalized epilepsyJacopo C DiFrancesco, Andrea Barbuti, Raffaella Milanesi, et al.
Oncotarget|March 10, 2016
Adipocytes WNT5a mediated dedifferentiation: a possible target in pancreatic cancer microenvironmentElena Zoico, Elena Darra, Vanni Rizzatti, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 15, 2020
Cortical network dysfunction revealed by magnetoencephalography in carriers of spinocerebellar ataxia 1 or 2 mutationElisa Visani, Caterina Mariotti, Lorenzo Nanetti, et al.
Metabolism: Clinical and Experimental|March 12, 2002
Efficacy and safety of the new 60-mg formulation of the long-acting somatostatin analog lanreotide in the treatment of acromegalyMaria Rosaria Ambrosio, Paola Franceschetti, Marta Bondanelli, et al.
Pageof 70